A potential approach toward the management of sepsis: The extracorporeal cytokine hemadsorption therapy

Abstract

AbstractInfectious diseases are among the most common cause of morbidity and mortality among hospitalized patients while systemic inflammatory response syndrome is primarily attributed to the imbalance between pro‐inflammatory and anti‐inflammatory cytokines. Despite the improvements in the antibiotherapy alternatives and diagnostic modalities, the morbidity and mortality rates of sepsis and septic shock are relatively high among patients admitted to the intensive care units. Extracorporeal cytokine hemadsorption therapies are therapeutic approaches for such patient group with promising early results that especially have grown during COVID‐19 pandemic. In this narrative review, our aim is to evaluate the current pre‐clinical and clinical knowledge regarding the use of cytokine filtration systems among patients with septic shock.